The involvement of the spleen during chronic phase of Schistosoma mansoni infection in galectin-3-/- mice

Histology and Histopathology

Volumn 27, Issue 8, 2012, Pages 1109-1120

  Brand, Camila ^a   Oliveira, Felipe L ^a   Takiya, Christina M ^a   Palumbo, Antônio ^a   Hsu, Daniel K ^d   Liu, Fu Tong ^d   Borojevic, Radovan ^a   Chammas, Roger ^b,c   El Cheikh, Márcia C ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Agronomic Institute of São Paulo   (Brazil)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

B lymphocyte; Galectin 3; Macrophage; Schistosoma mansoni; Spleen

Indexed keywords

EID: 84864910502     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Acosta-Rodriguez E.V., Montes C.L., Motran C.C., Zuniga E.I., Liu F.T., Rabinovich G.A. and Gruppi A. (2004). Galectin-3 mediates IL-4-induced survival and differentiation of B cells: functional cross-talk and implications during Trypanosoma cruzi infection. J. Immunol. 172, 493-502.
2. Barondes S.H., Castronovo V., Cooper D.N., Cummings R.D., Drickamer K., Feizi T., Gitt M.A., Hirabayashi J., Hughes C. and Kasai K. (1994). Galectins: a family of animal beta-galactosidebinding lectins. Cell 76, 597-598.
3. Borojevic R. (1992). Experimental murine schistosomiasis mansoni: establishment of the chronic phase of the disease. Mem. Inst. Oswaldo. Cruz. 87 (Suppl 4), 171-174.
4. Boros D.L., Pelley R.P. and Warren K.S. (1975). Spontaneous modulation of granulomatous hypersensitivity in schistosomiasis mansoni. J. Immunol. 114, 1437-1441.
5. Breuilh L., Vanhoutte F., Fontaine J., van Stijn C.M., Tillie-Leblond I., Capron M., Faveeuw C., Jouault T., van Die I., Gosset P. and Trottein F. (2007). Galectin-3 modulates immune and inflammatory responses during helminthic infection: impact of galectin-3 deficiency on the functions of dendritic cells. Infect. Immun. 75, 5148-5157.
6. Cummings R.D. and Nyame A.K. (1996). Glycobiology of schistosomiasis. FASEB J. 10, 838-848.
7. Dietz A.B., Bulur P.A., Knutson G.J., Matasic R. and Vuk-Pavlovic S. (2000). Maturation of human monocyte-derived dendritic cells studied by microarray hybridization. Biochem. Biophys. Res. Commun. 275, 731-738.
8. Domingo E.O. and Warren K.S. (1968). Endogenous desensitization: changing host granulomatou response to schistosome eggs at different stages of infection with schistosoma mansoni. Am. J. Pathol. 52, 369-379.
9. El-Cheikh M.C. and Borojevic R. (1990). Extramedullar proliferation of eosinophil granulocytes in chronic schistosomiasis mansoni is mediated by a factor secreted by inflammatory macrophages. Infect. Immun. 58, 816-821.
10. El-Cheikh M.C., Dutra H.S. and Borojevic R. (1991). Eosinophil granulocyte proliferation and differentiation in schistosomal granulomas are controlled by two cytokines. Lab. Invest. 64, 93-97.
11. El-Cheikh M.C., Dutra H.S., Minoprio P. and Borojevic R. (1994). Increase of B-lymphocyte number and activity during experimental murine schistosomiasis mansoni. Braz. J. Med. Biol. Res. 27, 1605-1617.
12. El-Cheikh M.C., Bonomo A.C., Rossi M.I., Pinho Mde F. and Borojevic R. (1998). Experimental murine schistosomiasis mansoni: modulation of the B-1 lymphocyte distribution and phenotype expression. Immunobiology 199, 51-62.
13. Grzych J.M., Pearce E., Cheever A., Caulada Z.A., Caspar P., Heiny S., Lewis F. and Sher A. (1991). Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni. J. Immunol. 146, 1322-1327.
14. Hokke C.H. and Yazdanbakhsh M. (2005). Schistosome glycans and innate immunity. Parasite Immunol. 27, 257-264.
15. Hotez P.J., Bottazzi M.E., Franco-Paredes C., Ault S.K. and Periago M.R. (2008). The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination. PLoS Negl. Trop. Dis. 2, e300.
16. Hsu D.K., Yang R.Y., Pan Z., Yu L., Salomon D.R., Fung-Leung W.P. and Liu F.T. (2000). Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am. J. Pathol. 156, 1073-1083.
17. Kim H., Lee J., Hyun J.W., Park J.W., Joo H. and Shin T. (2007). Expression and immunohistochemical localization of galectin-3 in various mouse tissues. Cell. Biol. Int. 31, 655-662.
18. Ko A.I., Drager U.C. and Harn D.A. (1990). A Schistosoma mansoni epitope recognized by a protective monoclonal antibody is identical to the stage-specific embryonic antigen 1. Proc. Natl. Acad. Sci. USA 87, 4159-4163.
19. Lenzi H.L., Oliveira D.N., Pelajo-Machado M., Borojevic R. and Lenzi J.A. (1996). Coelom-associated lymphomyeloid tissue (milky spots): site of lymphoid and myelomonocytic cell generation. Braz. J. Med. Biol. Res. 29, 19-24.
20. Linehan S.A., Martinez-Pomares L. and Gordon S. (2000). Macrophage lectins in host defence. Microbes Infect. 2, 279-288.
21. Liu F.T., Hsu D.K., Zuberi R.I., Kuwabara I., Chi E.Y. and Henderson W.R., Jr. (1995). Expression and function of galectin-3, a betagalactoside-binding lectin, in human monocytes and macrophages. Am. J. Pathol. 147, 1016-1028.
22. Lopes L.M., Pereira M.A., Gerken S.E. and Vaz N. (1990). Polyclonal activation of B lymphocytes during experimental infection with Schistosoma mansoni. Parasitology 100 Pt 1, 83-91.
23. MacKinnon A.C., Farnworth S.L., Hodkinson P.S., Henderson N.C., Atkinson K.M., Leffler H., Nilsson U.J., Haslett C., Forbes S.J. and Sethi T. (2008). Regulation of alternative macrophage activation by galectin-3. J. Immunol. 180, 2650-2658.
24. Montalvao F., Almeida G.M., Silva E.M., Borges V.M., Vasconcellos R., Takiya C.M., Lopes M.F., Nunes M.P. and DosReis G.A. (2010). Apoptotic lymphocytes treated with IgG from Trypanosoma cruzi infection increase TNF-alpha secretion and reduce parasite replication in macrophages. Eur. J. Immunol. 40, 417-425.
25. Nyame A.K., Leppanen A.M., DeBose-Boyd R. and Cummings R.D. (1999). Mice infected with Schistosoma mansoni generate antibodies to LacdiNAc (GalNAc beta 1-->4GlcNAc) determinants. Glycobiology 9, 1029-1035.
26. Oliveira F.L., Brand C., Paula A.A., Arcanjo K.D., Hsu D.K., Liu F.T., Takiya C.M., Borojevic R., Chammas R. and El-Cheikh M.C. (2011). Lack of Galectin-3 Disturbs Mesenteric Lymph Node Homeostasis and B Cell Niches in the Course of Schistosoma mansoni Infection. PLoS One 6, e19216.
27. Oliveira F.L., Chammas R., Ricon L., Fermino M.L., Bernardes E.S., Hsu D.K., Liu F.T., Borojevic R. and El-Cheikh M.C. (2009). Galectin-3 regulates peritoneal B1-cell differentiation into plasma cells. Glycobiology 19, 1248-1258.
28. Oliveira F.L., Frazao P., Chammas R., Hsu D.K., Liu F.T., Borojevic R., Takiya C.M. and El-Cheikh M.C. (2007). Kinetics of mobilization and differentiation of lymphohematopoietic cells during experimental murine schistosomiasis in galectin-3-/-mice. J. Leukoc. Biol. 82, 300-310.
29. Rabinovich G.A., Rubinstein N. and Toscano M.A. (2002). Role of galectins in inflammatory and immunomodulatory processes. Biochim. Biophys. Acta 1572, 274-284.
30. Robijn M.L., Wuhrer M., Kornelis D., Deelder A.M., Geyer R. and Hokke C.H. (2005). Mapping fucosylated epitopes on glycoproteins and glycolipids of Schistosoma mansoni cercariae, adult worms and eggs. Parasitology 30, 67-77.
31. Sano H., Hsu D.K., Yu L., Apgar J.R., Kuwabara I., Yamanaka T., Hirashima M. and Liu F.T. (2000). Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J. Immunol. 165, 2156-2164.
32. Sano H., Hsu D.K., Apgar J.R., Yu L., Sharma B.B., Kuwabara I., Izui S. and Liu F.T. (2003). Critical role of galectin-3 in phagocytosis by macrophages. J. Clin. Invest. 112, 389-397.
33. Sundblad V., Croci D.O. and Rabinovich G.A. (2011). Regulated expression of galectin-3, a multifunctional glycan-binding protein, in haematopoietic and non-haematopoietic tissues. Histol. Histopathol. 26, 247-265.
34. van den Berg T.K., Honing H., Franke N., van Remoortere A., Schiphorst W.E., Liu F.T., Deelder A.M., Cummings R.D., Hokke C.H. and van Die I. (2004). LacdiNAc-glycans constitute a parasite pattern for galectin-3-mediated immune recognition. J. Immunol. 173, 1902-1907.
35. van Remoortere A., Hokke C.H., van Dam G.J., van Die I., Deelder A.M. and van den Eijnden D.H. (2000). Various stages of schistosoma express Lewis(x), LacdiNAc, GalNAcbeta1-4 (Fucalpha1-3)GlcNAc and GalNAcbeta1-4(Fucalpha1-2Fucalpha1-3)GlcNAc carbohydrate epitopes: detection with monoclonal antibodies that are characterized by enzymatically synthesized neoglycoproteins. Glycobiology 10, 601-609.
36. Vindelov L.L., Hansen H.H., Christensen I.J., Spang-Thomsen M., Hirsch F.R., Hansen M. and Nissen N.I. (1980). Clonal heterogeneity of small-cell anaplastic carcinoma of the lung demonstrated by flowcytometric DNA analysis. Cancer Res. 40, 4295-4300.
37. Von L. (1964). Studies on granuloma formation. Iii. Antigen sequestration and destruction in the schistosome pseudotubercle. Am. J. Pathol. 45, 75-94.
38. Warren K.S. (1980). The relevance of schistosomiasis. N. Engl. J. Med. 303, 203-206.
39. Weinberg D.F., Baldo-Correa E., Lenzi H.L. and Borojevic R. (1992). Schistosoma mansoni: peritoneal plasmacytogenesis and polypoid transformation of mesenteric milky spots in infected mice. Exp. Parasitol. 74, 408-416.